Bone Adhesive
-
DTIF Project Consortium Progress Meeting
Biomaterials, Bone Adhesive, Bone Disease Solution, Bone Healing, Collaboration, Development, Government Funding, ResearchIt was fantastic to welcome the Enterprise Ireland #DTIF consortium team to our Shannon Headquarters at the start of September for a project progress meeting. Thank you to Nicholas Dunne and the DCU postgraduate team, the Dolmen Design & Innovation team, as well as Jackie FitzGerald of Enterprise Ireland for making the trip! #DTIF #disruptivetechnology…
-
Exciting New Hires for Biomimetic Innovations
PBC Biomed would like to welcome our two newest members to the Biomimetic Innovations Ltd team – Quality Specialist Annmarie Donnellan (left) and Director of Operations Ann Marie Ryan (right). We are delighted to have you both on board – exciting times ahead for BMI and the development of OsStic® Technology! #newhire #operations #biomimeticinnovations #acceleratingmedicalinnovation
-
DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.
Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®. PBC Biomed leads a consortium for this development project, which is…
-
FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler.Â
Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…
-
PBC Biomed to Lead Consortium in Development of Bone Adhesive
 PBC Biomed_Our Why.mp4 SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) — PBC Biomed, an Irish-based Medical Device Company, will lead a consortium comprised of Biodesign Europe and SFI Research Centre for Advanced Manufacturing (I-Form) at Dublin City University and Dolmen Design & Innovation, a Dublin-based product design company, in developing a bone adhesive for…
-
DSM and PBC Partnership to develop regenerative bone adhesives
DSM and PBC Biomed partner to develop regenerative bone adhesives for safer, more cost-effective surgical procedures. Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and PBC Biomed, a medical device design and development company, have signed an agreement to jointly design and develop novel materials for medical devices. Initially, the agreement…
Search News Items
Categories
- Awards (5)
- Biomaterials (14)
- Biovet (11)
- Bone Adhesive (16)
- Bone Disease Solution (4)
- Bone Healing (12)
- Certification (1)
- Client (2)
- Collaboration (18)
- Conferences (16)
- Contract Manufacturing (2)
- Day One Trauma Charity (1)
- Development (11)
- Events (48)
- Government Funding (2)
- Lectures (6)
- Medical Devices (8)
- Medical Implants (6)
- Memphis Office (7)
- New Hire (8)
- On TV/Radio (2)
- Press Release (8)
- Publications (7)
- ReFeelNerveRepairSolution (4)
- Regenerative Medicine (13)
- Relationship-building (18)
- Research (12)
- Sports & Social (3)
- Sports Partners (4)
- Student Placements (2)
- Uncategorized (6)
- Upcoming Events (4)
- US Office (4)